Ketamine May Be an Effective Alternative to Opioids
By HospiMedica International staff writers Posted on 02 Aug 2018 |
Image: New research suggests ketamine can rapidly reduce suicidal thoughts in the depressed (Photo courtesy of Erowid).
Low-dose ketamine (LDK) is as effective as opioids for the control of acute pain in the in the emergency department (ED), and could serve as an analgesic alternative.
The systematic review and meta-analysis of randomized controlled trials, conducted by researchers at Washington University School of Medicine (WUSTL; St. Louis, MO, USA), and Maimonides Medical Center (New York, NY, USA), compared intravenous (IV) opioids to LDK for relief of acute pain in the ED setting. Studies in which the control group initially received opioids prior to LDK were excluded. Search strategy was comprised of changes in visual analog scale (VAS) or numeric rating scale pain scales.
In all, three studies met the criteria for inclusion in the meta-analysis. Results showed that compared to pain scale reduction with morphine, LDK was not inferior. No severe adverse events with ketamine were reported in any study, but higher rates of non-severe adverse events were shown. In addition, the emergence delirium or dissociation usually associated with larger doses of ketamine were not apparent with LDK. Another potential complication, laryngospasm, was also rare. The study was published on July 17, 2018, in Academic Emergency Medicine.
“Opioids are commonly prescribed for the treatment of acute pain, but due to the epidemic of opioid misuse, analgesic alternatives are being explored. Ketamine appears to be a legitimate and safe alternative to opioids for treating acute pain in the ED,” concluded senior author Evan Schwarz, MD, of WUSTL. “Although adverse events associated with ketamine were reported, few appeared to be clinically significant. Emergency physicians can feel comfortable using it instead of opioids.”
Ketamine is commonly used as a rapidly acting, dissociative anesthetic agent that can provide analgesia, sedation, and amnesia for rapid sequence intubation in critically ill patients. Short- and long-term effects include increased heart rate and blood pressure, nausea, vomiting, numbness, depression, amnesia, hallucinations, and potentially fatal respiratory problems. Sub-anesthetic ketamine is often administered intraoperatively for postoperative analgesia due to the detached, dreamlike state it creates.
Related Links:
Washington University School of Medicine
Maimonides Medical Center
The systematic review and meta-analysis of randomized controlled trials, conducted by researchers at Washington University School of Medicine (WUSTL; St. Louis, MO, USA), and Maimonides Medical Center (New York, NY, USA), compared intravenous (IV) opioids to LDK for relief of acute pain in the ED setting. Studies in which the control group initially received opioids prior to LDK were excluded. Search strategy was comprised of changes in visual analog scale (VAS) or numeric rating scale pain scales.
In all, three studies met the criteria for inclusion in the meta-analysis. Results showed that compared to pain scale reduction with morphine, LDK was not inferior. No severe adverse events with ketamine were reported in any study, but higher rates of non-severe adverse events were shown. In addition, the emergence delirium or dissociation usually associated with larger doses of ketamine were not apparent with LDK. Another potential complication, laryngospasm, was also rare. The study was published on July 17, 2018, in Academic Emergency Medicine.
“Opioids are commonly prescribed for the treatment of acute pain, but due to the epidemic of opioid misuse, analgesic alternatives are being explored. Ketamine appears to be a legitimate and safe alternative to opioids for treating acute pain in the ED,” concluded senior author Evan Schwarz, MD, of WUSTL. “Although adverse events associated with ketamine were reported, few appeared to be clinically significant. Emergency physicians can feel comfortable using it instead of opioids.”
Ketamine is commonly used as a rapidly acting, dissociative anesthetic agent that can provide analgesia, sedation, and amnesia for rapid sequence intubation in critically ill patients. Short- and long-term effects include increased heart rate and blood pressure, nausea, vomiting, numbness, depression, amnesia, hallucinations, and potentially fatal respiratory problems. Sub-anesthetic ketamine is often administered intraoperatively for postoperative analgesia due to the detached, dreamlike state it creates.
Related Links:
Washington University School of Medicine
Maimonides Medical Center
Latest Critical Care News
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration